{"id":56382,"date":"2023-05-01T15:04:48","date_gmt":"2023-05-01T13:04:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/"},"modified":"2023-05-01T15:04:48","modified_gmt":"2023-05-01T13:04:48","slug":"therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/","title":{"rendered":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market<\/i><\/p>\n<p>ELK CITY, Idaho&#8211;(BUSINESS WIRE)&#8211;Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the \u201cliving timebomb\u201d condition of aortic aneurysms using stem cell derived exosomes.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/5\/logo-tsoi.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg\"><\/a><\/p>\n<p>\nThe aorta is the body\u2019s main artery, carrying blood from the heart up to the head and down to the other major organs. An aortic aneurysm is a balloon-like bulge in the aorta that in many cases continues to grow. The larger its diameter, the more likely it is that it will burst, which is associated with fatality. The results announced today, for which a patent was filed, demonstrate administration of stem cell derived exosomes suppress growth of aortic aneurysms in an animal model.<\/p>\n<p>\n\u201cAortic aneurysms affect an estimated at 1.3\u20138.9% of men and 1.0\u20132.2% of women. Of these, a significant portion are ineligible for surgical or endovascular approaches. The basis of VasoSome Vascular is to utilize stem cell exosomes to stabilize and possibly even reverse growth of aortic aneurysms,\u201d said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International. \u201cBased on our clinical experiences using JadiCells and other stem cell products, I am confident as a physician that the field of aortic aneurysms is a relatively wide-open space for application of regenerative medicine. I am excited to assist the new company in advancing its initial milestones.\u201d<\/p>\n<p>\nVasoSome Vascular is currently performing Investigational New Drug (IND)-enabling studies and hopes to file with the FDA by the end of 2023 to initiate a Phase I\/II clinical trial.<\/p>\n<p>\n\u201cWe are excited to be commercializing the utilization of these nanoparticles called \u2018exosomes\u2019 in overcoming limitations of existing stem cell therapies to diffuse the \u2018living time bomb\u2019 known as aortic aneurysms,\u201d said Timothy Dixon, President, and CEO of Therapeutic Solutions International. \u201cBy leveraging the potency of our regenerative medicine base, we are grateful to be able to generate so many new companies across diverse areas of biology in order to advance patient treatments and augment shareholder value to the highest extent possible.\u201d<\/p>\n<p>\n<b>About Therapeutic Solutions International, Inc.<\/b><\/p>\n<p>\nTherapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company&#8217;s corporate website is <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.therapeuticsolutionsint.com&amp;esheet=53390586&amp;newsitemid=20230501005362&amp;lan=en-US&amp;anchor=www.therapeuticsolutionsint.com&amp;index=1&amp;md5=937900219e16bc769512c62f9cbec77e\" rel=\"nofollow noopener\" shape=\"rect\">www.therapeuticsolutionsint.com<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nTimothy G. Dixon<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#x6f;:&#x69;&#114;&#x40;&#x74;s&#x6f;&#105;&#x6d;&#x61;i&#x6c;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#114;&#64;t&#x73;&#x6f;&#105;m&#x61;&#x69;&#108;&#46;&#x63;&#x6f;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market ELK CITY, Idaho&#8211;(BUSINESS WIRE)&#8211;Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the \u201cliving timebomb\u201d condition of aortic aneurysms using stem cell derived exosomes. The aorta is the body\u2019s main artery, carrying blood from &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56382","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market ELK CITY, Idaho&#8211;(BUSINESS WIRE)&#8211;Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the \u201cliving timebomb\u201d condition of aortic aneurysms using stem cell derived exosomes. The aorta is the body\u2019s main artery, carrying blood from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T13:04:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy\",\"datePublished\":\"2023-05-01T13:04:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/\"},\"wordCount\":400,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005362\\\/en\\\/1778997\\\/21\\\/logo-tsoi.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/\",\"name\":\"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005362\\\/en\\\/1778997\\\/21\\\/logo-tsoi.jpg\",\"datePublished\":\"2023-05-01T13:04:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005362\\\/en\\\/1778997\\\/21\\\/logo-tsoi.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005362\\\/en\\\/1778997\\\/21\\\/logo-tsoi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend","og_description":"Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market ELK CITY, Idaho&#8211;(BUSINESS WIRE)&#8211;Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the \u201cliving timebomb\u201d condition of aortic aneurysms using stem cell derived exosomes. The aorta is the body\u2019s main artery, carrying blood from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-01T13:04:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy","datePublished":"2023-05-01T13:04:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/"},"wordCount":400,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/","url":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/","name":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg","datePublished":"2023-05-01T13:04:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230501005362\/en\/1778997\/21\/logo-tsoi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/therapeutic-solutions-international-launches-vasosome-vascular-inc-based-on-successful-treatment-of-aortic-aneurysms-using-patent-pending-exosome-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56382"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56382\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}